Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Fierce Pharma
Daiichi Sankyo targets global top 5 oncology rank by 2035
By 2030, Daiichi envisions its revenues will reach more than 3 trillion yen ($19.1 billion), with 2.3 trillion yen from its oncology portfolio.
Angus Liu
May 11, 2026 10:22am
Labcorp raises guidance on diagnostics, lab services growth
Apr 30, 2026 8:31am
Fierce Pharma
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
Icon reveals accounting investigation, withdraws 2025 guidance
Feb 12, 2026 11:12am
Fierce Pharma
Astellas lifts forecast as Vyloy surge counters trial miss
Feb 5, 2026 11:00am
GE HealthCare posts higher revenues amid turbulent tariffs
Feb 5, 2026 10:45am